|
Loading...
| ||||||||||||||
Recent Publications by AstraZeneca Pharmaceuticals: |  | |
| Biomarkers of Collecting Duct Injury in Han-Wistar and Sprague-Dawley Rats Treated with N-Phenylanthranilic Acid.
N-phenylanthranilic acid is a chloride channel blocker that causes renal... | AstraZeneca Pharmaceuticals, Macclesfield, Cheshire, UK. | Toxicol Pathol. 2012 Feb 1.
DOI Direct Link |
| Medicinal chemistry matters - a call for discipline in our discipline.
Medicinal chemistry makes a vital contribution to small molecule drug... | AstraZeneca Pharmaceuticals, Cardiovascular and Gastrointestinal Research, | Drug Discov Today. 2012 Jan 25.
DOI Direct Link |
| A shrinkage-based comparative assessment of observed-to-expected disproportionality measures.
PURPOSE: Disproportionality analysis is an important tool for interpreting... | Patient Safety, AstraZeneca Pharmaceuticals LP, Wilmington, DE, United | Pharmacoepidemiol Drug Saf. 2012 Jan 30. doi: 10.1002/pds.2349.
DOI Direct Link |
| Structure-based drug design on membrane protein targets: human integral membrane protein 5-lipoxygenase-activating protein.
Leukotrienes are biologically active lipid metabolites of arachidonic acid... | Discovery Sciences, AstraZeneca Pharmaceuticals, Waltham, MA, USA, | Methods Mol Biol. 2012;841:267-90.
DOI Direct Link |
| Multiparameter exploration of piperazine derivatives as delta-opioid receptor agonists for CNS indications.
A novel series of piperazine derivatives exhibits sub-nanomolar binding... | AstraZeneca Pharmaceuticals, 1800 Concord Pike, Wilmington, DE 19850, USA. | Bioorg Med Chem Lett. 2012 Jan 15;22(2):1169-73. Epub 2011 Dec 7.
DOI Direct Link |